載入...
Liposomal adjuvant development for leishmaniasis vaccines
Leishmaniasis is a parasitic disease that ranges in severity from skin lesions to fatality. Since long-lasting protection is induced upon recovery from cutaneous leishmaniasis, development of an effective vaccine is promising. However, there is no vaccine for use in humans yet. It seems limited effi...
Na minha lista:
| 發表在: | Ther Adv Vaccines |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697592/ https://ncbi.nlm.nih.gov/pubmed/29201374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051013617741578 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|